Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

Phase 2 Recruiting 40 enrolled University of Rochester National Cancer Institute (NCI) · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation.

Timeline

Start: 2025-07-26
Primary completion: 2026-12-31
Completion: 2027-06-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Fucoidan	Unknown	4 g	—

Indications

No indication recorded.